Functional copy-number alterations in cancer

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Taylor, Barry S ^a,b   Barretina, Jordi ^c,d   Socci, Nicholas D ^a   DeCarolis, Penelope ^a   Ladanyi, Marc ^a   Meyerson, Matthew ^c,d   Singer, Samuel ^a   Sander, Chris ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; CHROMOSOME DISORDER; CHROMOSOME DUPLICATION; CHROMOSOME NUMBER; CONTROLLED STUDY; DISEASE ACTIVITY; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; ONCOGENE; SOFT TISSUE SARCOMA; BIOLOGICAL MODEL; CHROMOSOME ABERRATION; CLUSTER ANALYSIS; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN GENOME; METHODOLOGY; NEOPLASM; PHENOTYPE; POISSON DISTRIBUTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GENOMICS; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASMS; PHENOTYPE; POISSON DISTRIBUTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 58149112821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003179     Document Type: Article

References (63)

1. Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
2. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, et al. (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031-1037.
3. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, et al. (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316: 1039-1043.
4. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139.
5. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500.
6. Pao W, Miller V, Zakowski M, Doherty J, Politi K, et al. (2004) EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 101: 13306-13311.
7. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
8. Pinkel D, Albertson DG (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 Suppl: S11-17.
9. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
10. Emanuel BS, Saitta SC (2007) From microscopes to microarrays: dissecting recurrent chromosomal rearrangements. Nat Rev Genet 8: 869-883.
11. Lai WR, Johnson MD, Kucherlapati R, Park PJ (2005) Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data. Bioinformatics 21: 3763-3770.
12. Willenbrock H, Fridlyand J (2005) A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics 21: 4084-4091.
13. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, et al. (2004) High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A 101: 9067-9072.
14. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, et al. (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A 102: 9625-9630.
15. Diskin SJ, Eck T, Greshock J, Mosse YP, Naylor T, et al. (2006) STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res 16: 1149-1158.
16. Guttman M, Mies C, Dudycz-Sulicz K, Diskin SJ, Baldwin DA, et al. (2007) Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays. PLoS Genet 3: e143.
17. Shah SP, Lam WL, Ng RT, Murphy KP (2007) Modeling recurrent DNA copy number alterations in array CGH data. Bioinformatics 23: i450-458.
18. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci U S A 104: 20007-20012.
19. National Cancer Institute NHGRI (2007) The Cancer Genome Atlas.
20. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, et al. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55: 4670-4675.
21. Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester E, Lui WO, et al. (2000) Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 18: 1001-1005.
22. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, et al. (2006) Copy number variation: new insights in genome diversity. Genome Res 16: 949-961.
23. Inoue K, Lupski JR (2002) Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 3: 199-242.
24. Lupski JR (2004) Hotspots of homologous recombination in the human genome: not all homologous sequences are equal. Genome Biol 5: 242.
25. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
26. Myers S, Bottolo L, Freeman C, McVean G, Donnelly P (2005) A fine-scale map of recombination rates and hotspots across the human genome. Science 310: 321-324.
27. Frazer KAPI, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
28. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
29. Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, et al. (2006) High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9: 313-325.
30. Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, et al. (2008) The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82: 685-695.
31. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature.
32. Mack TM (1995) Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen. Cancer 75: 211-244.
33. Fletcher CDM, Unni KK, Mertens F, World Health Organization, International Academy of Pathology (2002) Pathology and genetics of tumours of soft tissue and bone. Lyon Oxford: IARC Press; Oxford University Press (distributor). 427 p.
34. Ladanyi M, Antonescu CR, Dal Cin P (2008) Cytogenetic and Molecular Genetic Pathology of Soft Tissue Tumors. In: Enzinger & Weiss's Soft Tissue Tumors; Weiss SW, Goldblum JR, eds. Mosby.
35. Fritz B, Schubert F, Wrobel G, Schwaenen C, Wessendorf S, et al. (2002) Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res 62: 2993-2998.
36. Rieker RJ, Joos S, Bartsch C, Willeke F, Schwarzbach M, et al. (2002) Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer 99: 68-73.
37. Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244: 381-391.
38. Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, et al. (2007) Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67: 6626-6636.
39. Helman LJ, Meltzer P (2003) Mechanisms of sarcoma development. Nat Rev Cancer 3: 685-694.
40. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, et al. (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. Jama 278: 1262-1267.
41. Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, et al. (2007) Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1. Oncogene 26: 3473-3481.
42. King AA, Debaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93: 388-392.
43. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, et al. (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91: 355-358.
44. Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, et al. (2005) Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol 36: 1037-1048.
45. Strathdee G (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 12: 373-379.
46. Mariani O, Brennetot C, Coindre JM, Gruel N, Ganem C, et al. (2007) JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas. Cancer Cell 11: 361-374.
47. Kanazawa A, Tsukada S, Kamiyama M, Yanagimoto T, Nakajima M, et al. (2005) Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 330: 505-510.
48. Rosen ED, MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
49. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, et al. (1997) Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90: 4699-4704.
50. Takahashi N, Kawada T, Yamamoto T, Goto T, Taimatsu A, et al. (2002) Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J Biol Chem 277: 16906-16912.
51. Tanaka K, Miyamoto N, Shouguchi-Miyata J, Ikeda JE (2006) HFM1, the human homologue of yeast Mer3, encodes a putative DNA helicase expressed specifically in germ-line cells. DNA Seq 17: 242-246.
52. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The Genomic Landscapes of Human Breast and Colorectal Cancers. Science.
53. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
54. Rubin AF, Green P (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500.
55. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
56. Getz G, Hofling H, Mesirov JP, Golub TR, Meyerson M, et al. (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500.
57. Forrest WF, Cavet G (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 317: 1500; author reply 1500.
58. Olshen AB, Venkatraman ES, Lucito R, Wigler M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572.
59. McVean GA, Myers SR, Hunt S, Deloukas P, Bentley DR, et al. (2004) The fine-scale structure of recombination rate variation in the human genome. Science 304: 581-584.
60. Coop G, Wen X, Ober C, Pritchard JK, Przeworski M (2008) High-Resolution Mapping of Crossovers Reveals Extensive Variation in Fine-Scale Recombination Patterns Among Humans. Science.
61. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
62. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
63. Major JE (2007) Genomic mutation consequence calculator. Bioinformatics 23: 3091-3092.